Off-note, we did not include in Table 2: (a) CDK3, whose activity on the cell cycle has not clearly been identified; (b) CDK8, a transcriptional regulator, whose activity has been designated as both tumor promoter and suppressor, and a p53 co-activator27–30; and (c) any of the cyclins. Here, TP53 is linked to neoplasm.